Item 2. Properties.
4K characters. Original on sec.gov · Markdown
Item 2. Properties.
The following is a summary of Cooper's principal facilities as of October 31, 2022. We generally lease our office and operations facilities but own several manufacturing and research and development facilities, including 298,852 square feet in the United Kingdom, 350,600 square feet in Costa Rica, 78,767 square feet in New York and 33,630 square feet in Texas. Our lease agreements expire at various dates through the year 2045. We believe our properties are suitable and adequate for our businesses.
| Location | Approximate Square Feet | Operations | |||||||||
| AMERICAS | |||||||||||
| United States: | |||||||||||
| California | 201,143 | Executive offices; CooperVision manufacturing, research & development and administrative offices; CooperSurgical research & development, distribution and administrative offices | |||||||||
| New York | 349,047 | CooperVision and CooperSurgical distribution and administrative offices | |||||||||
| New Jersey | 37,700 | CooperSurgical research and development, distribution and administrative offices | |||||||||
| Connecticut | 285,538 | CooperSurgical distribution and administrative offices | |||||||||
| Arizona | 45,000 | CooperVision manufacturing | |||||||||
| Puerto Rico | 563,284 | CooperVision manufacturing, research and development and distribution | |||||||||
| Canada | 60,035 | CooperVision manufacturing and administrative office; CooperSurgical research & development, distribution and administrative offices | |||||||||
| Brazil | 38,623 | CooperVision distribution and administrative office | |||||||||
| Other Americas | 45,135 | CooperVision distribution and administrative offices; CooperSurgical research & development, distribution and administrative offices | |||||||||
| EMEA | |||||||||||
| United Kingdom | 691,131 | CooperVision manufacturing, distribution, research & development and administrative offices; CooperSurgical research & development, administrative offices | |||||||||
| Hungary | 330,149 | CooperVision manufacturing | |||||||||
| Belgium | 279,967 | CooperVision distribution | |||||||||
| Spain | 181,145 | CooperVision distribution and administrative office; CooperSurgical administrative office | |||||||||
| Netherlands | 86,027 | CooperVision administrative offices; CooperSurgical research & development and distribution | |||||||||
| Other EMEA | 125,005 | CooperVision distribution and administrative offices; CooperSurgical administrative offices | |||||||||
| ASIA PACIFIC | |||||||||||
| Japan | 103,533 | CooperVision distribution and administrative offices; CooperSurgical laboratory/research & development | |||||||||
| Australia | 32,844 | CooperVision marketing and distribution; CooperSurgical research & development and distribution | |||||||||
| Other Asia Pacific | 91,244 | CooperVision distribution, marketing and administrative offices; CooperSurgical marketing and administrative office |
THE COOPER COMPANIES, INC. AND SUBSIDIARIES
Previous: Item 1B. Unresolved Staff Comments. · Next: Item 3. Legal Proceedings.
Sponsor Sponsor this sector. One slot per industry, shown on every filing in it. Details